Corcept Therapeutics Incorporated (CORT)
Debt-to-capital ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 506,705 | 461,679 | 421,614 | 529,584 | 501,842 | 473,364 | 442,326 | 407,811 | 375,806 | 540,229 | 522,675 | 510,802 | 523,338 | 489,680 | 453,698 | 409,489 | 371,182 | 334,376 | 298,053 | 285,755 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $506,705K)
= 0.00
Based on the data provided, Corcept Therapeutics Inc has consistently maintained a debt-to-capital ratio of 0.00 for the past eight quarters. This indicates that the company has not utilized any debt as a source of funding and has relied solely on equity for its capital structure during this period. A debt-to-capital ratio of 0.00 signifies a conservative approach to financing, as the company is not taking on any debt to finance its operations or growth. It also suggests that Corcept Therapeutics Inc may have a strong balance sheet with sufficient equity to support its business activities without the need for debt financing. This stability in the debt-to-capital ratio may be viewed positively by investors and creditors as it indicates a low-risk financial position and potential financial strength.
Peer comparison
Dec 31, 2023